Review of Initiating and administering guidance services.

Reviews the book, Initiating and administering guidance services, by S. A. Hamrin (1953). Hamrin addressed this book to school principals and superintendents because "no worthwhile program of guidance services can thrive or even exist long without sympathetic understanding and encouragement of school administrators. It is hoped that this volume will aid in promoting such understanding and assistance." This book appears to be a combination of Hamrin's lectures illustrated by excerpts from term papers written by Hamrin's students. The reviewer was annoyed by the interspersion of the amateurish illustrations in the midst of Hamrin's expert and mature discussions of the various topics. Hamrin has demonstrated in his previous books that his own experience has been rich and sufficiently varied to provide pertinent illustrative material. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Short-term group therapy for couples in a health maintenance organization.

Describes a 15-session group treatment program for couples in a health maintenance organization (HMO). The program demonstrates principles of efficiency, economy, integration of services, and prevention in an HMO. It is argued that the location of the program in a comprehensive organized health care setting enhances the efficacy of the treatment. (14 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Discrimination of mirror images by young children.

Conducted 3 experiments to investigate the effects of introducing mirror-image configurations into orientation and position discriminations. Ss were 4-8 yr. old children. Results of 2 experiments suggest that the question of mirror images may be irrelevant to the way in which young children differentiate orientation and position; i.e., as many errors were made in successive comparisons of obliques when the obliques were not mirror images as when they were. Similarly when they had to discriminate the positions of dots in squares, Ss confused left with right and up with down as much when the choice squares were asymmetrical as when they were symmetrical. It is suggested that young children adopt a binary match-mismatch code in orientation and position comparisons, which tells them whether lines parallel each other or not and whether objects are in line with each other or not. This code can solve some discriminations but not others. When the code fails, it does so as much with asymmetrical as with symmetrical configurations. (19 ref.) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Audience-induced inhibition of overt practice during learning.

Three experiments with 204 undergraduates examined the hypothesis that an audience can inhibit overt practice and thereby impair learning of unfamiliar words and enhance learning of familiar words. This hypothesis was derived from an analysis of motoric and symbolic mediation during learning. In comparison with learning while alone, the results show that the audience inhibited overt practice of unfamiliar and familiar words and that reduced practice was detrimental to learning unfamiliar words. Inhibition of overt practice with an audience enhanced learning of familiar words in only 1 of the experiments. Instructions to practice overtly reduced the audience-inhibition effect in learning unfamiliar words. The studies are discussed in the context of drive-theory explanations for social facilitation effects in learning. (20 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Theory and research on small groups.

Review of book: R. Scott Tindale et. al (Eds.) Theory and Research on Small Groups. New York: Plenum Press. 1998, 277 pp. Reviewed by Mark F. Stasson, Michael J. Markus, and Jason W. Hart. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Autobiographies of mental health clients: Psychologists' uses and recommendations.

More than 80% of practicing psychologists recommend self-help books to their psychotherapy clients, but only 33% recommend autobiographies written by mental health patients. In this study, 362 psychologists (38% response) provided clinical information and evaluative ratings on such published autobiographical accounts. The effect of reading autobiographies during treatment was typically considered somewhat helpful. The titles and evaluative ratings of 40 leading autobiographies are provided as a resource for the practitioner; the most valued were An Unquiet Mind, Nobody Nowhere, Darkness Visible, Out of the Depths, and Girl Interrupted. The clinical advantages of recommending published autobiographies to clients are reviewed. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Design and characterisation of long-R3-insulin-like growth factor-I muteins which show resistance to pepsin digestion

Site-directed mutagenesis was used to construct pepsin-resistant, single-point mutations of the N-terminal extended IGF-I analogue, long-R3-IGF-I. In order to identify the most susceptible sites, the kinetics of long-R3-IGF-I digestion by purified porcine pepsin were determined. Pepsin initially cleaved the Leu10-Phe11 bond in the N-terminal extension peptide to generate FVN-R3-IGF-I, followed in rapid succession by cleavage at Gln15-Phe16, Tyr24-Phe25, Leu10-Val11 and Met59-Tyr60 in the IGF-I moiety. Single-point mutations at these sites were designed on the basis of the preferred cleavage bonds for pepsin, as well as amino acid substitutions less likely to disturb protein structure. These included Leu10Val, Phe16Ala, Phe25Leu, Asp53Glu and Met59Gln. All five muteins retained growth-promoting activity equivalent to or higher than that of IGF-I. In terms of pepsin susceptibility, Leu10Val and Asp53Glu were degraded as rapidly as the parent long-R3-IGF-I, Met59Gln and Phe25Leu were partially stabilised, and Phe16Ala showed a marked improvement in stability over a wide range of pepsin:substrate ratios. Accordingly, the Phe16Ala mutein, long-R3A16-IGF-I, has potential for oral applications to enhance gastric growth and repair.     

Hypertensive cardiac hypertrophy--is genetic variance the missing link?

1. Hypertensive cardiac hypertrophy is a major independent predictor of adverse cardiovascular events. In man the cardiac response to increased afterload is very variable, even when ambulatory blood pressure monitoring is used. Analysis of breeding experiments using normotensive and hypertensive rat strains, human twin studies and other data indicate that genetic factors play a significant role in regulating cardiac mass; in other words, a large component of total variability is accounted for by genetic variance. 2. The observation that some patients with only mild-to-moderate hypertension exhibit gross left ventricular hypertrophy (LVH) similar to the inherited hypertrophic cardiomyopathies such as familial hypertrophic cardiomyopathy (FHC) and Friedreich's ataxia (FA) has prompted us to investigate the hypothesis that genetic factors associated with excessive myocardial hypertrophy, viz. mutations in FHC and FA genes alter the hypertrophic response of the heart to pressure overload. Here we review briefly three lines of study: (i) association analysis to test whether the allele frequencies differ in hypertensive patients with or without left ventricular hypertrophy; (ii) characterization of the cardiac manifestations of FA to understand the mechanism by which the heart is affected in a disease associated with pathology in a subgroup of neurons, and (iii) creation of transgenic models to facilitate the investigation of the interaction between hypertrophic stimuli and underlying genetic predisposition. 3. Information on the nature of the cardiac-mass-modifying genes involved may be useful not only for selecting high risk patients in strategies aimed at preventing the development of LVH, but also in opening new avenues of research on the reprogramming of cardiac myocytes to encourage them to hypertrophy in situations where cardiac muscle has been damaged or is hypoplastic.     

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

BACKGROUND: In 1982, the National Surgical Adjuvant Breast and Bowel Project initiated a randomized, double-blinded, placebo-controlled trial (B-14) to determine the effectiveness of adjuvant tamoxifen therapy in patients with primary operable breast cancer who had estrogen receptor-positive tumors and no axillary lymph node involvement. The findings indicated that tamoxifen therapy provided substantial benefit to patients with early stage disease. However, questions arose about how long the observed benefit would persist, about the duration of therapy necessary to maintain maximum benefit, and about the nature and severity of adverse effects from prolonged treatment. PURPOSE: We evaluated the outcome of patients in the B-14 trial through 10 years of follow-up. In addition, the effects of 5 years versus more than 5 years of tamoxifen therapy were compared. METHODS: In the trial, patients were initially assigned to receive either tamoxifen at 20 mg/day (n = 1404) or placebo (n = 1414). Tamoxifen-treated patients who remained disease free after 5 years of therapy were then reassigned to receive either another 5 years of tamoxifen (n = 322) or 5 years of placebo (n = 321). After the study began, another group of patients who met the same protocol eligibility requirements as the randomly assigned patients were registered to receive tamoxifen (n = 1211). Registered patients who were disease free after 5 years of treatment were also randomly assigned to another 5 years of tamoxifen (n = 261) or to 5 years of placebo (n = 249). To compare 5 years with more than 5 years of tamoxifen therapy, data relating to all patients reassigned to an additional 5 years of the drug were combined. Patients who were not reassigned to either tamoxifen or placebo continued to be followed in the study. Survival, disease-free survival, and distant disease-free survival (relating to failure at distant sites) were estimated by use of the Kaplan-Meier method; differences between the treatment groups were assessed by use of the logrank test. The relative risks of failure (with 95% confidence intervals [CIs]) were determined by use of the Cox proportional hazards model. Reported P values are two-sided. RESULTS: Through 10 years of follow-up, a significant advantage in disease-free survival (69% versus 57%, P < .0001; relative risk = 0.66; 95% CI = 0.58-0.74), distant disease-free survival (76% versus 67%, P < .0001; relative risk = 0.70; 95% CI = 0.61-0.81), and survival (80% versus 76%, P = .02; relative risk = 0.84; 95% CI = 0.71-0.99) was found for patients in the group first assigned to receive tamoxifen. The survival benefit extended to those 49 years of age or younger and to those 50 years of age or older. Tamoxifen therapy was associated with a 37% reduction in the incidence of contralateral (opposite) breast cancer (P = .007). Through 4 years after the reassignment of tamoxifen-treated patients to either continued-therapy or placebo groups, advantages in disease-free survival (92% versus 86%, P = .003) and distant disease-free survival (96% versus 90%, P = .01) were found for those who discontinued tamoxifen treatment. Survival was 96% for those who discontinued tamoxifen compared with 94% for those who continued tamoxifen treatment (P = .08). A higher incidence of thromboembolic events was seen in tamoxifen-treated patients (through 5 years, 1.7% versus 0.4%). Except for endometrial cancer, the incidence of second cancers was not increased with tamoxifen therapy. CONCLUSIONS AND IMPLICATIONS: The benefit from 5 years of tamoxifen therapy persists through 10 years of follow-up. No additional advantage is obtained from continuing tamoxifen therapy for more than 5 years.